PI
COCHW icon

PineBridge Investments’s Envoy Medical Warrant COCHW Stock Holding History

PineBridge Investments’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-163,574
Closed -$14.6K – 579
2023
Q3 		$14.6K Buy
+163,574
New +$9.95K ﹤0.01% 658

Other funds holding COCHW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

PineBridge Investments's COCHW Position: Q4 2023 in Review

PineBridge Investments sold out of Envoy Medical Warrant (COCHW) in Q4 2023, closing a stake of 163,574 shares — an estimated $14.6K sold.

PineBridge Investments first reported a position in COCHW in Q3 2023 and held it in 1 quarter. The position peaked at $14.6K in Q3 2023. 54 funds tracked by Wall St. Rank hold COCHW as of Q4 2023.

  • PineBridge Investments reported no remaining Envoy Medical Warrant position as of Q4 2023 after selling out during the quarter.
  • PineBridge Investments sold 163,574 Envoy Medical Warrant shares in Q4 2023, an estimated $14.6K.
  • PineBridge Investments first reported a position in Envoy Medical Warrant in Q3 2023 and held it in 1 quarter.
  • PineBridge Investments's Envoy Medical Warrant position peaked at $14.6K in Q3 2023.
  • 54 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q4 2023.

Based on PineBridge Investments's 13F filing for Q4 2023, filed 13 Feb 2024.